Click here for more information about Algenuity
Click here for more information about LiqofluxPhenometrics Buy 3 Get 1 Free
Visit cricatalyst.com!Evodos Separation Technology

Health & Nutrition

Astaxanthin in newly patented formula for eye health

June 14, 2017
AlgaeIndustryMagazine.com

In the new formulation astaxanthin is quickly incorporated into the eye’s vitreous humor where it acts as a potent blue light filter to protect the macular pigment degradation on the rod and cone surfaces.

The US Patent and Trademark Office recently awarded Patent No. 9,610,313 to Florida-based Valensa International for its EyePro MD® formula, which claims eye healthcare benefits related to its blend of lutein, zeaxanthin and astaxanthin mixed with omega-3 essential oils from krill, algae or perilla seed.

The EyePro MD® patented formulas feature the process of purifying the all-natural ingredients through extraction and stabilization using Valensa’s proprietary O2B® peroxidation blocker technology and its Supercritical CO2 extraction technology.

The patent, titled “Eye Health Composition and Method using Plant-Derived Seed Extract Rich in Essential Fatty Acids Derived from Perilla Seed and Carotenoids,” outlines the numerous health benefits this combination of all-natural, ingredients provides in EyePro MD®. For example, the formula delivers macular carotenoid supplementation, phospholipids for enhanced bioavailability and omega-3 essential fatty acids known to support heart and cognitive functions.

“We have designed a small soft gel loaded with a potent combination of ingredients that can be absorbed efficiently to optimize eye health,” said Dr. John Minatelli, Senior Vice President of Business Development at Valensa. “Now with the patent IP in place, distributors and manufactures from the food and nutraceutical industry can include EyePro MD® in their products knowing there’s nothing else like it on the market.”

Research conducted in Japan on astaxanthin for the treatment of eye fatigue, accommodation and protection from blue light damage have confirmed that astaxanthin alone improved eye fatigue caused by blue light induced oxidative stress (Digital Eye) in humans.

According to Dr. Minatelli, these studies also confirmed that astaxanthin is quickly incorporated into the eye’s vitreous humor where it acts as a potent blue light filter to protect the macular pigment degradation on the rod and cone surfaces. This allows the carotenoid portfolio to reduce oxidative stress to the associated retinal and macular cells thus protecting and supporting eye health.

Read More

More Like This…

Copyright ©2010-2020 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Kim Kaplan reports for the U.S. Department of Agriculture’s Agricultural Research Service, in Baton Rouge, Louisiana, that a microscopic algae could provide a complete an...
Mazda U.K. has announced that they are currently involved in joint research projects and studies as part of an ongoing industry-academia-government collaboration to promo...
Biotechnologists from Aarhus University have demonstrated how the rare properties of an atypical light-dependent enzyme can be used with a photo-bio-catalytic continuous ...
Researchers at Los Alamos National Laboratory and partner institutions have provided the first published report of algae using raw plants as a carbon energy source. The r...
Bloomberg News reports that a newly approved Chinese drug for Alzheimer’s will start clinical trials in the U.S. and Europe this year as the country’s first novel therapy...
The problem of access to safe drinking water in most parts of Bangladesh is a persistent challenge. Now, a team of scientists from Uppsala University, Sweden, and Dhaka U...
JapanNews.com reports that Euglena Co., a Tokyo-based maker of nutritional supplements, is spending ¥5.8 billion ($5.3 million USD) on building a test refinery that conve...
Tavelmout Biofarm (TVMB), a Bruneian subsidiary of Tabérumo Corporation — a pioneer in the large-scale cultivation of spirulina using photobioreactors — has launched thei...
Israeli-based Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health New Zealand, Ltd. (Supreme) to supply the rapidly growing markets in Ch...
Maiki Sherman, traveling with New Zealand Prime Minister Jacinda Ardern, reports for 1News Now that new innovation partnerships have been signed between New Zealand and J...
The Utah Science Technology and Research (USTAR) initiative, a technology-based economic development program funded by the state of Utah, has awarded a $175,320 grant for...
Nestlé has entered into a partnership with Corbion to develop the next generation of microalgae-based ingredients, enabling the companies to deliver sustainable, tasty an...